Skip to main content
23andMe Holding Co. (ME)
NASDAQ: ME · Real-Time Price · USD
2.420
-0.320 (-11.68%)
At close: Feb 21, 2025, 4:00 PM
2.500
+0.080 (3.31%)
After-hours: Feb 21, 2025, 7:20 PM EST

23andMe Holding Co. Revenue

23andMe Holding Co. had revenue of $60.26M in the quarter ending December 31, 2024, with 34.67% growth. This brings the company's revenue in the last twelve months to $208.78M, down -15.81% year-over-year. In the fiscal year ending March 31, 2024, 23andMe Holding Co. had annual revenue of $219.64M, down -26.66%.

Revenue (ttm)
$208.78M
Revenue Growth
-15.81%
P/S Ratio
0.29
Revenue / Employee
$358,720
Employees
582
Market Cap
64.92M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024219.64M-79.85M-26.66%
Mar 31, 2023299.49M27.60M10.15%
Mar 31, 2022271.89M27.97M11.47%
Mar 31, 2021243.92M-61.54M-20.15%
Mar 31, 2020305.46M-135.44M-30.72%
Mar 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

ME News

More News